|
Volumn 156, Issue 10, 2012, Pages 752-753
|
To the Editor
a b c d e f g |
Author keywords
[No Author keywords available]
|
Indexed keywords
HEMOGLOBIN A1C;
METFORMIN;
ORAL ANTIDIABETIC AGENT;
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ANTIDIABETIC AGENT;
CONSENSUS;
DATA BASE;
DIABETES MELLITUS;
HEALTH CARE PERSONNEL;
HUMAN;
LETTER;
LIFESTYLE MODIFICATION;
MEDICAL LITERATURE;
MEDICAL RESEARCH;
MEDICAL SOCIETY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATHOPHYSIOLOGY;
PRACTICE GUIDELINE;
PRESCRIPTION;
PRIORITY JOURNAL;
STANDARDIZATION;
NOTE;
STANDARD;
DIABETES MELLITUS, TYPE 2;
HUMANS;
HYPOGLYCEMIC AGENTS;
METFORMIN;
PRACTICE GUIDELINES AS TOPIC;
THIAZOLIDINEDIONES;
|
EID: 84861120415
PISSN: 00034819
EISSN: 15393704
Source Type: Journal
DOI: 10.7326/0003-4819-156-10-201205150-00020 Document Type: Letter |
Times cited : (1)
|
References (4)
|